Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s):  LBLTF

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.


TSXV:LBL.H - Post by User

Comment by DigitalSpurson Mar 31, 2020 4:07pm
131 Views
Post# 30865726

RE:RE:RE:Trial

RE:RE:RE:TrialNo need to get upset.

Thank you for proving my point on this - J&J with a networth of $360 Billion had a 8% jump in stock price

If this stock here gets even a fraction of that in confirmation that they are a candidate, or any other stem cell research being discussed, well you know where the share price goes.

With the following FDA tweet, situation changing by the minute on number of infected and death rate, you can expect J&J to start a lot earlier than September - bet on that!


https://twitter.com/AnandShahFDA/status/1245058696377520129?s=20


I
'll probably take a stake in J&J soon for this reason as well.
<< Previous
Bullboard Posts
Next >>